Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control

Behavioural Neurology
Danyan ChenChuanTao Zuo

Abstract

Dementia with Lewy bodies (DLB) is the second most common degenerative dementia of the central nervous system. The technique 18F-fluorodeoxyglucose positron emission tomography (18F FDG PET) was used to investigate brain metabolism patterns in DLB patients. Conventional statistical methods did not consider intern metabolism transforming connections between various brain regions; therefore, most physicians do not understand the underlying neuropathology of DLB patients. In this study, 18F FDG-PET images and graph-theoretical methods were used to investigate alterations in whole-brain intrinsic functional connectivity in a Chinese DLB group and healthy control (HC) group. This experimental study was performed on 22 DLB patients and 22 HC subjects in Huashan Hospital, Shanghai, China. Experimental results indicate that compared with the HC group, the DLB group has severely impaired small-world network. Compared to those of the HC group, the clustering coefficients of the DLB group were higher and characteristic path lengths were longer, and in terms of global efficiencies, those of the DLB group was also lower. Moreover, four significantly altered regions were observed in the DLB group: Inferior frontal gyrus, opercular part (IFG....Continue Reading

References

Nov 15, 1976·Acta Neuropathologica·K KosakaA Hori
Jan 1, 1994·Acta Neuropathologica·D W DicksonJ Q Trojanowski
Jun 12, 1998·Nature·D J Watts, S H Strogatz
Nov 3, 2001·Physical Review Letters·V Latora, M Marchiori
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Feb 6, 2007·PLoS Computational Biology·Sophie Achard, Ed Bullmore
Feb 22, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Lisa MosconiMony J de Leon
May 2, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yong HeAlan Evans
Feb 5, 2009·Nature Reviews. Neuroscience·Ed Bullmore, Olaf Sporns
Apr 10, 2009·Neuroscience Letters·Laura Silveira-MoriyamaTamas Revesz
Jun 12, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Martijn P van den HeuvelHilleke E Hulshoff Pol
Oct 13, 2009·NeuroImage·Mikail Rubinov, Olaf Sporns
Dec 29, 2009·NeuroImage·Andrew ZaleskyEdward T Bullmore
May 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Dardo Tomasi, Nora D Volkow
Jun 29, 2010·Current Opinion in Neurology·Yong He, Alan Evans
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·S Neil VaishnaviMarcus E Raichle
Nov 10, 2013·PloS One·Martin GöttlichUlrike M Krämer
Feb 25, 2014·Neuropsychology Review·Emily L Dennis, Paul M Thompson
Jul 25, 2014·Neurology·Jonathan Graff-RadfordKejal Kantarci
Dec 3, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·John T O'BrienJim Lloyd
Mar 24, 2015·PloS One·Hiroyasu Inoue, Yang-Yu Liu
Jul 16, 2015·Frontiers in Human Neuroscience·Jinhui WangYong He
Jan 2, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Dmitry TitovIgor Yakushev
Jun 17, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Silvia P CaminitiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative (ADNI)

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

SPM
MATLAB
GRETNA
DCM2NII
Statistical Parametric Mapping 8 ( SPM8 )
Brain Connectivity Toolkit ( BCT
IFGoperc
R

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.